Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients

Diabetes Care

Volumn 21, Issue 7, 1998, Pages 1129-1132

  De Luis, Daniel A ^a,b   Lahera, Marcos ^a   Cantón, Rafael ^a   Boixeda, Daniel ^a   San Román, Antonio L ^a   Aller, Rocio ^a   De La Calle, Hermenegildo ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK FACTORS;

EID: 0031822260     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.7.1129     Document Type: Article

References (32)

1. Mendall M, Goggin P, Levy J, Molineaux N, Strachan D, Camm A: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437-439, 1994
2. Glynn J: Helicobacter pylori and the heart. Lancet 334:143-146, 1991
3. Martin de Argila C, Boixeda D, Canton R, Gisbert JP, Fuertes A: High seroprevalence of Helicobacter pylori infection in coronary heart disease (Letter). Lancet 346:310, 1995
4. Murray LJ, Bamford KB, Dermot PJOR, Evelyn EMC, Evans AE: H. pylori infection: relation with cardiovascular risk factors, ischemic heart disease, and social class. Br Heart J 74:497-501, 1995
5. Miragliotta G, Del Prete R, Mosca A: Helicobacter pylori infection and coronary heart disease (Letter). Lancet 344:751, 1994
6. Patel P, Mendall MA, Carrington D, Strachan DP, Leathman N, Molineaux N, Levy J, Blakeston T, Seymour CA, Camm AJ, Northfield TC: Association of H. pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311:711-714, 1995
7. Lindberg G, Eklund G, Gullberg B, Restam L: Serum sialic acid concentration and cardiovascular motality BMJ 302:143-146, 1991
8. Yarnell JW, Baker IA, Sweetnam PM, Binton D, O'Brien JR, Whitehead PJ: Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell Collaborative Heart Diseases studies. Circulation 83:836-844, 1991
9. Meade TW Brozovic M, Chakrabarti RR, Haines AR Imeson JD, Melows S: Hemostatic functions and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet ii:533-537, 1986
10. Gallin JI, Ky D, O'Leary WM: Serum lipids in infections. N Engl J Med 281:1081-1086, 1969
11. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312:1061-1065, 1996
12. Patel P, Crington D, Strachan D, Leatham E, Goggin P, Northfield T: Fibrinogen: a link between chronic infection and coronary heart disease (Letter). Lancet 343:1634- 1635, 1994
13. Perdichizzi G, Bortari M, Pallio S, Fera MT, Carbone M, Barresi G: Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol 19:149-154, 1996
14. Oldenburg B, Diepersloot RJ, Hoekstra JB: High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 41:458-461, 1996
15. Scragg R, Baker J, Metcalf P, Dryson E: Prevalence of diabetes mellitus and impaired glucose tolerance in New Zealand multiracial workforce. N Z Med J 104:395-397, 1991
16. Early Treatment Diabetic Retinopathy Study Research Group: Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report No. 10. Ophthalmology 98:786-806, 1991
17. Reina J, Salva F, Alomar P: Análisis de la prevalencia de anticuerpos anti-Helicobacter pylori detectados en la población humana sana. Rev Esp Enferm Dig 76:151-154, 1989
18. Morgando A, Sanseverino P, Perotto C, Molino F, Gai V, Ponzetto A: Helicobacter pylori seropositivity in myocardial infarction (Letter). Lancet 345:1380, 1995
19. Kweider M, Lowe GDO, Murray GD, Kinane DF, McGwn DA: Dental disease, fibrinogen and white cell count: links with myocardial infarction? Scott Med J 38:73-74, 1993
20. Mattila KJ, Neiminen MS, Vltonene W, Rsi VP, Kesaniemi Y, Syrjala S: Association between dental health and acute myocardial infarction, BMJ 298:779-781, 1989
21. Crabtree JE, Shallcross TM, Healtley RV Wyatt JI: Mucosal tumor necrosis factor and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32:1473-1477, 1991
22. Harlan JM, Harker LA, Reidy MA, Gadusek CM, Schwartz SM, Striker GE: Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest 48:269-274, 1983
23. Harlan JM, Harker LA, Striker GE, Weaver LJ: Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res 29:15-26, 1983
24. Kapp A, Luger T, Mly DG, Travers RI, Skray RK: Hyperlipidemia fatty liver and brosulphthalein retention in rabbits injected intravenously with bacterial endotoxins, J Lipid Res 5:563-568, 1964
25. Fiser RH, Denniston JC, Beisel WR: Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins, J Infect Dis 125:54-60, 1972
26. Kaufman RL, Matson CF, Rowberg AH: Defective lipid disposal mechanisms during bacterial infection in Rhesus monkeys. Metabolism 25:615-624, 1976
27. Akerlund B, Carlson L, Jarstrand C: Dysliproteinemia in patients with severe bacterial infections. Scand J Inject Dis 18:539-545, 1986
28. Samalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR: Changes in serum lipoproteins pattern induced by acute infections. Metabolism 37:859-865, 1988
29. Kerttula Y, Vaara M, Phyhälä L: Effect of bacterial lipopolysaccharide on serum high density lipoprotein cholesterol in rabbits. Atherosclerosis 52:123-126, 1984
30. Hiramatsu K, Rosen H, Heinecke JW, Wolbuer G, Chair A: Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis 7:55-60, 1977
31. Cathcart MK, McNally K, Morel DW, Chisolm GM: The role of speroxide anion in human monocyte-mediated oxidation and conversion of LDL to a cytoxin. J Immunol 142:1963-1969, 1988
32. Lopes Virela MF, Griffith RL, Shunk KA, Virella GT: Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies. Anerioscler Thromb Vase Biol 59:37-52, 1991